[Federal Register Volume 88, Number 122 (Tuesday, June 27, 2023)]
[Notices]
[Pages 41628-41629]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-13547]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2023-0035]


Advisory Committee on Immunization Practices; Amended Notice of 
Meeting

AGENCY: Centers for Disease Control and Prevention, Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) announces 
an amendment to the following meeting of the Advisory Committee on 
Immunization Practices (ACIP). This meeting is open to the public.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, Committee Management 
Specialist, Advisory Committee on Immunization Practices, National 
Center for Immunization and Respiratory Diseases, Centers for Disease 
Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8, Atlanta, 
Georgia 30329-4027. Telephone: (404) 639-8836; Email: [email protected].

SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the 
meeting of the Advisory Committee on Immunization Practices (ACIP); 
June 21, 2023, 8 a.m. to 5:15 p.m., EDT, June 22, 2023, 8 a.m. to 5 
p.m., EDT, and June 23, 2023, 8 a.m. to 1 p.m., EDT (times subject to 
change, see the ACIP website for updates: http://www.cdc.gov/vaccines/acip/index.html), in the original Federal Register notice.
    Notice of the virtual meeting was published in the Federal Register 
on Friday, May 5, 2023, Volume 88, Number 87, pages 29132-29133.
    Notice of the virtual meeting is being amended to update the times 
in the dates section, the matters to be considered, and the procedure 
for oral public comment, which should read as follows:
    Dates: The meeting will be held on June 21, 2023, 8 a.m. to 5:30 
p.m., EDT, June 22, 2023, 8 a.m. to 5:30 p.m., EDT, and June 23, 2023, 
8 a.m. to 2:40 p.m., EDT (times subject to change, see the ACIP website 
for updates: https://www.cdc.gov/vaccines/acip/index.html).
    Written comments must be received between June 5-16, 2023.
    Matters To Be Considered: The agenda will include discussions on 
mpox vaccines, influenza vaccines, pneumococcal vaccines, meningococcal 
vaccines, polio vaccine, respiratory syncytial virus vaccine pediatric/
maternal, respiratory syncytial virus vaccine in adults, dengue 
vaccines, chikungunya vaccine, informational session by CDC 
Immunization Safety Office, and COVID-19 vaccines. Recommendation votes 
on influenza vaccines, pneumococcal vaccines, polio vaccines, and 
respiratory syncytial virus vaccine in adults are scheduled. Vaccines 
for Children votes on influenza and pneumococcal vaccines are 
scheduled. Agenda items are subject to change as priorities dictate. 
For more information on the meeting agenda, visit https://www.cdc.gov/vaccines/acip/meetings/index.html.
    Procedure for Oral Public Comment: All persons interested in making 
an oral public comment on June 21 or June 22, 2023, at the ACIP meeting 
must submit a request at http://www.cdc.gov/vaccines/acip/meetings/index.html no later than 11:59 p.m., EDT, June 16, 2023, according to 
the instructions provided.
    If the number of persons requesting to speak is greater than can be 
reasonably accommodated during the scheduled time, CDC will conduct a 
lottery to determine the speakers for the scheduled public comment 
session. CDC staff will notify individuals regarding their request to 
speak by email by June 20, 2023. To accommodate the significant 
interest in participation in the oral public comment session of ACIP 
meetings, each speaker will be limited to three minutes, and each

[[Page 41629]]

speaker may only speak once per meeting.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

(Authority: 5 U.S.C. 1001 et seq.)

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-13547 Filed 6-26-23; 8:45 am]
BILLING CODE 4163-18-P